• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿得腺苷 A2A 拮抗剂伊曲茶碱对前额皮质 6-OHDA 损伤大鼠认知功能的影响。

Effects of the adenosine A2A antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex.

机构信息

Pharmacological Research Laboratories, Research Division, Kyowa Hakko Kirin Co., Ltd, 1188 Shimotogari, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8731, Japan.

出版信息

Psychopharmacology (Berl). 2013 Dec;230(3):345-52. doi: 10.1007/s00213-013-3158-x. Epub 2013 Jun 10.

DOI:10.1007/s00213-013-3158-x
PMID:23748382
Abstract

RATIONALE

Altered cognitive function is a common feature of both the early and later stages of Parkinson's disease (PD) that involves alterations in cortical dopamine content. Adenosine A2A antagonists, such as istradefylline, improve motor function in PD, but their effect on cognitive impairment has not been determined.

OBJECTIVE

The present study investigated whether impairment of working memory due to the loss of dopaminergic input into the prefrontal cortex (PFC) is reversed by administration of istradefylline. We also evaluated whether A2A antagonist administration modulates dopamine levels in the PFC.

METHODS

Bilateral lesions of the dopaminergic input to the PFC were produced in rats using 6-hydroxydopamine (6-OHDA). Cognitive performance was evaluated using an object recognition task and delayed alternation task. The effects of istradefylline, donepezil and methamphetamine on cognitive performance were examined. In addition, the effect of istradefylline on extracellular dopamine levels in the PFC was studied.

RESULTS

PFC dopamine levels and cognitive performance were significantly reduced by 6-OHDA lesioning. Istradefylline, donepezil and methamphetamine improved cognitive performance of PFC-lesioned rats. Istradefylline increased dopamine levels in the PFC in both normal and PFC-lesioned rats.

CONCLUSIONS

PFC dopaminergic input plays an important role in working memory performance. Blockade of A2A receptors using istradefylline reverses the changes in cognitive function, and this may be due to an increase in PFC dopamine content. Adenosine A2A receptor antagonists not only improve motor performance in PD but may also lead to improved cognition.

摘要

背景

认知功能改变是帕金森病(PD)早期和晚期的共同特征,涉及皮质多巴胺含量的改变。腺苷 A2A 拮抗剂,如伊曲茶碱,可改善 PD 的运动功能,但它们对认知障碍的影响尚未确定。

目的

本研究旨在探讨伊曲茶碱是否可以逆转由于前额叶皮质(PFC)多巴胺能传入减少引起的工作记忆损伤。我们还评估了 A2A 拮抗剂给药是否调节 PFC 中的多巴胺水平。

方法

使用 6-羟多巴胺(6-OHDA)在大鼠中产生 PFC 多巴胺能传入的双侧损伤。使用物体识别任务和延迟交替任务评估认知表现。检查了伊曲茶碱、多奈哌齐和苯丙胺对认知表现的影响。此外,还研究了伊曲茶碱对 PFC 细胞外多巴胺水平的影响。

结果

PFC 多巴胺水平和认知表现因 6-OHDA 损伤而显著降低。伊曲茶碱、多奈哌齐和苯丙胺改善了 PFC 损伤大鼠的认知表现。伊曲茶碱增加了正常和 PFC 损伤大鼠 PFC 中的多巴胺水平。

结论

PFC 多巴胺能传入在工作记忆表现中起重要作用。使用伊曲茶碱阻断 A2A 受体可逆转认知功能的变化,这可能是由于 PFC 多巴胺含量的增加。腺苷 A2A 受体拮抗剂不仅改善 PD 中的运动性能,而且可能导致认知改善。

相似文献

1
Effects of the adenosine A2A antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex.阿得腺苷 A2A 拮抗剂伊曲茶碱对前额皮质 6-OHDA 损伤大鼠认知功能的影响。
Psychopharmacology (Berl). 2013 Dec;230(3):345-52. doi: 10.1007/s00213-013-3158-x. Epub 2013 Jun 10.
2
Effects of the adenosine A2A receptor antagonist on cognitive dysfunction in Parkinson's disease.腺苷A2A受体拮抗剂对帕金森病认知功能障碍的影响。
Int Rev Neurobiol. 2014;119:169-89. doi: 10.1016/B978-0-12-801022-8.00008-8.
3
Antidepressant activity of the adenosine A2A receptor antagonist, istradefylline (KW-6002) on learned helplessness in rats.腺苷A2A受体拮抗剂异喹啉(KW-6002)对大鼠习得性无助的抗抑郁活性。
Psychopharmacology (Berl). 2014 Jul;231(14):2839-49. doi: 10.1007/s00213-014-3454-0. Epub 2014 Feb 2.
4
The role of glutamate mGlu5 and adenosine A2a receptor interactions in regulating working memory performance and persistent cocaine seeking in rats.谷氨酸代谢型谷氨酸受体5(mGlu5)与腺苷A2a受体相互作用在调节大鼠工作记忆表现及持续性可卡因觅求行为中的作用
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Dec 20;103:109979. doi: 10.1016/j.pnpbp.2020.109979. Epub 2020 May 26.
5
In vitro pharmacological profile of the A2A receptor antagonist istradefylline.阿替利珠单抗的体外药理学特征。
Naunyn Schmiedebergs Arch Pharmacol. 2013 Nov;386(11):963-72. doi: 10.1007/s00210-013-0897-5. Epub 2013 Jun 29.
6
The adenosine A2A receptor antagonist, istradefylline enhances the anti-parkinsonian activity of low doses of dopamine agonists in MPTP-treated common marmosets.腺苷A2A受体拮抗剂异他林可增强低剂量多巴胺激动剂对MPTP处理的普通狨猴的抗帕金森病活性。
Eur J Pharmacol. 2015 Jan 15;747:160-5. doi: 10.1016/j.ejphar.2014.11.038. Epub 2014 Dec 11.
7
Fluvoxamine maleate effects on dopamine signaling in the prefrontal cortex of stressed Parkinsonian rats: Implications for learning and memory.马来酸氟伏沙明对应激帕金森病大鼠前额叶皮质多巴胺信号传导的影响:对学习和记忆的意义。
Brain Res Bull. 2017 Jun;132:75-81. doi: 10.1016/j.brainresbull.2017.05.014. Epub 2017 May 24.
8
Antidepressant-like activity of the adenosine A(2A) receptor antagonist, istradefylline (KW-6002), in the forced swim test and the tail suspension test in rodents.在强迫游泳试验和尾部悬挂试验中,腺苷 A(2A)受体拮抗剂伊曲茶碱(KW-6002)的抗抑郁样活性。
Pharmacol Biochem Behav. 2013 Dec;114-115:23-30. doi: 10.1016/j.pbb.2013.10.022. Epub 2013 Nov 4.
9
Decreased synaptic plasticity in the medial prefrontal cortex underlies short-term memory deficits in 6-OHDA-lesioned rats.内侧前额叶皮质突触可塑性降低是6-羟基多巴胺损伤大鼠短期记忆缺陷的基础。
Behav Brain Res. 2016 Mar 15;301:43-54. doi: 10.1016/j.bbr.2015.12.011. Epub 2015 Dec 18.
10
Unprecedented therapeutic potential with a combination of A2A/NR2B receptor antagonists as observed in the 6-OHDA lesioned rat model of Parkinson's disease.在帕金森病的6-羟基多巴胺损伤大鼠模型中观察到,A2A/NR2B受体拮抗剂联合使用具有前所未有的治疗潜力。
PLoS One. 2014 Dec 16;9(12):e114086. doi: 10.1371/journal.pone.0114086. eCollection 2014.

引用本文的文献

1
The Anti-Parkinsonian A2A Receptor Antagonist Istradefylline (KW-6002) Attenuates Behavioral Abnormalities, Neuroinflammation, and Neurodegeneration in Cerebral Ischemia: An Adenosinergic Signaling Link Between Stroke and Parkinson's Disease.抗帕金森病的 A2A 受体拮抗剂异他林(KW-6002)减轻脑缺血中的行为异常、神经炎症和神经退行性变:中风与帕金森病之间的腺苷能信号联系
Int J Mol Sci. 2025 Jun 13;26(12):5680. doi: 10.3390/ijms26125680.
2
Impact of istradefylline on motor and non-motor symptoms in patients with Parkinson's disease: Subanalysis of the ISTRA ADJUST PD.异他司林对帕金森病患者运动和非运动症状的影响:ISTRA ADJUST PD研究的亚组分析
Clin Park Relat Disord. 2025 Apr 17;12:100327. doi: 10.1016/j.prdoa.2025.100327. eCollection 2025.
3

本文引用的文献

1
Attentional set-shifting deficit in Parkinson's disease is associated with prefrontal dysfunction: an FDG-PET study.帕金森病的注意定势转移缺陷与前额叶功能障碍有关:一项 FDG-PET 研究。
PLoS One. 2012;7(6):e38498. doi: 10.1371/journal.pone.0038498. Epub 2012 Jun 7.
2
Cognitive impairment and dementia in Parkinson's disease.帕金森病中的认知障碍和痴呆。
Neurobiol Dis. 2012 Jun;46(3):590-6. doi: 10.1016/j.nbd.2012.03.029. Epub 2012 Mar 30.
3
Characteristic of cognitive decline in Parkinson's disease: a 1-year follow-up.帕金森病认知功能衰退的特征:一项为期1年的随访研究
Adolescent alcohol exposure disrupts episodic-like memory by impairing dopamine synapses in the mouse prelimbic cortex.青少年接触酒精会通过损害小鼠前额叶皮层中的多巴胺突触来破坏类似情景记忆。
Neuropharmacology. 2025 Mar 1;265:110255. doi: 10.1016/j.neuropharm.2024.110255. Epub 2024 Dec 4.
4
Trends on Novel Targets and Nanotechnology-Based Drug Delivery System in the Treatment of Parkinson's disease: Recent Advancement in Drug Development.新型靶点及基于纳米技术的药物传递系统治疗帕金森病的研究进展:药物研发的新进展。
Curr Drug Targets. 2024;25(15):987-1011. doi: 10.2174/0113894501312703240826070530.
5
Targeting the adenosine A receptor for neuroprotection and cognitive improvement in traumatic brain injury and Parkinson's disease.针对创伤性脑损伤和帕金森病的神经保护和认知改善的腺苷 A 受体。
Chin J Traumatol. 2024 May;27(3):125-133. doi: 10.1016/j.cjtee.2023.08.003. Epub 2023 Aug 25.
6
Promising biomarkers and therapeutic targets for the management of Parkinson's disease: recent advancements and contemporary research.帕金森病管理中有前景的生物标志物和治疗靶点:最新进展与当代研究
Metab Brain Dis. 2023 Mar;38(3):873-919. doi: 10.1007/s11011-023-01180-z. Epub 2023 Feb 20.
7
Striatopallidal adenosine A receptor modulation of goal-directed behavior: Homeostatic control with cognitive flexibility.纹状体腺苷 A 受体对目标导向行为的调节:具有认知灵活性的同型平衡控制。
Neuropharmacology. 2023 Mar 15;226:109421. doi: 10.1016/j.neuropharm.2023.109421. Epub 2023 Jan 10.
8
Therapeutic Approaches to Non-Motor Symptoms of Parkinson's Disease: A Current Update on Preclinical Evidence.帕金森病非运动症状的治疗方法:临床前证据的最新更新。
Curr Neuropharmacol. 2023;21(3):560-577. doi: 10.2174/1570159X20666221005090126.
9
The Pharmacological Potential of Adenosine A Receptor Antagonists for Treating Parkinson's Disease.腺苷 A 受体拮抗剂治疗帕金森病的药理学潜力。
Molecules. 2022 Apr 6;27(7):2366. doi: 10.3390/molecules27072366.
10
Quantifying the inverted U: A meta-analysis of prefrontal dopamine, D1 receptors, and working memory.量化倒 U 型关系:前额叶多巴胺、D1 受体与工作记忆的元分析。
Behav Neurosci. 2022 Jun;136(3):207-218. doi: 10.1037/bne0000512. Epub 2022 Apr 7.
Appl Neuropsychol. 2011 Oct;18(4):269-77. doi: 10.1080/09084282.2011.595453.
4
Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data.胆碱酯酶抑制剂对帕金森病痴呆的影响:临床数据回顾。
CNS Neurosci Ther. 2011 Oct;17(5):428-41. doi: 10.1111/j.1755-5949.2010.00166.x. Epub 2010 Jul 7.
5
Enhanced role of adenosine A(2A) receptors in the modulation of LTP in the rat hippocampus upon ageing.衰老过程中大鼠海马体 LTP 调制中腺苷 A(2A)受体作用增强。
Eur J Neurosci. 2011 Jul;34(1):12-21. doi: 10.1111/j.1460-9568.2011.07719.x. Epub 2011 May 25.
6
Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies.基因敲除研究揭示的中枢神经系统中腺苷受体的正常与异常功能
Biochim Biophys Acta. 2011 May;1808(5):1358-79. doi: 10.1016/j.bbamem.2010.12.018. Epub 2010 Dec 23.
7
Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease.帕金森病患者认知障碍和痴呆的神经心理学和临床异质性。
Lancet Neurol. 2010 Dec;9(12):1200-1213. doi: 10.1016/S1474-4422(10)70212-X. Epub 2010 Sep 27.
8
Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: a randomized, controlled study.依曲替酯(KW-6002)治疗帕金森病的临床疗效:一项随机对照研究。
Mov Disord. 2010 Jul 30;25(10):1437-43. doi: 10.1002/mds.23107.
9
Preferential enhancement of working memory in mice lacking adenosine A(2A) receptors.缺乏腺苷 A(2A)受体的小鼠工作记忆的优先增强。
Brain Res. 2009 Dec 15;1303:74-83. doi: 10.1016/j.brainres.2009.09.082. Epub 2009 Sep 26.
10
Age-related spatial working memory impairment is caused by prefrontal cortical dopaminergic dysfunction in rats.衰老相关的空间工作记忆损伤是由大鼠前额叶皮质多巴胺能功能障碍引起的。
Neuroscience. 2009 Sep 15;162(4):1192-201. doi: 10.1016/j.neuroscience.2009.05.023. Epub 2009 May 20.